- Patent Title: Cannabinoids for prophylactic treatment of involuntary weight loss
-
Application No.: US16464247Application Date: 2017-11-24
-
Publication No.: US10940136B2Publication Date: 2021-03-09
- Inventor: Agnes Kohl , Ralf Lenhard
- Applicant: AOP ORPHAN PHARMACEUTICALS AG
- Applicant Address: AT Vienna
- Assignee: AOP ORPHAN PHARMACEUTICALS AG
- Current Assignee: AOP ORPHAN PHARMACEUTICALS AG
- Current Assignee Address: AT Vienna
- Agency: Loza & Loza, LLP
- Agent Michael F. Fedrick
- Priority: EP16200498 20161124
- International Application: PCT/EP2017/080353 WO 20171124
- International Announcement: WO2018/096100 WO 20180531
- Main IPC: A61K31/352
- IPC: A61K31/352 ; A61P3/04 ; A61P35/00 ; A61K9/00 ; A61K45/06
Abstract:
The present invention provides a new use for cannabinoids in the prevention of pre-cachexia or cachexia in a patient suffering from cancer, wherein said cannabinoid is administered at low dosage and wherein administration is started prior to chemotherapy and is maintained for at least the duration of the chemotherapy.
Public/Granted literature
- US20190388383A1 CANNABINOIDS FOR PROPHYLACTIC TREATMENT OF INVOLUNTARY WEIGHT LOSS Public/Granted day:2019-12-26
Information query
